XML 36 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities:    
Net income (loss) $ (26,455) $ 30,946
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 14,445 11,089
Amortization 44,562 39,644
Amortization of debt issuance costs 2,486 2,459
Impairment loss 2,778 1,799
Excess tax benefit from stock-based compensation (7,970) (28,167)
Stock-based compensation expense 25,169 20,906
Deferred income tax benefit, net (13,702) (1,236)
Provision for losses on accounts receivable 5,490 3,798
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (13,279) (11,575)
Prepaid expenses and other current assets 263 (2,306)
Deposits and other assets 411 (68)
Accounts payable and other liabilities 30,085 24,712
Deferred revenue 5,433 4,035
Net cash provided by operating activities 69,716 96,036
Investing activities:    
Proceeds from sale and settlement of investments 1,900 1,150
Purchases of property and equipment and other assets (27,953) (20,865)
Acquisitions, net of cash acquired (177,476) (584,218)
Net cash used in investing activities (203,529) (603,933)
Financing activities:    
Proceeds from long-term debt 0 550,000
Payments of long-term debt (15,000) (313,125)
Payments of debt issuance costs 0 (9,969)
Payments of deferred consideration 0 (1,344)
Excess tax benefit from stock-based compensation 7,970 28,167
Repurchase of restricted stock to satisfy tax withholding obligations (15,816) (49,998)
Proceeds from equity offering, net of transaction costs 0 529,360
Proceeds from exercise of stock options and employee stock purchase plan 5,350 5,157
Net cash provided by (used in) financing activities (17,496) 738,248
Effect of foreign currency exchange rates on cash and cash equivalents (194) (109)
Net increase (decrease) in cash and cash equivalents (151,503) 230,242
Cash and cash equivalents at the beginning of period 527,012 255,953
Cash and cash equivalents at the end of period $ 375,509 $ 486,195